The study involved administering AL001 to 5XFAD mice, a recognized model for Alzheimer’s research, to compare its effects against ... Both treatments did not negatively impact the mice’s body weight ...

NEU-411, a brain-penetrant, potent and selective kinase inhibitor, has potential to slow disease progression in up to 30% of people with LRRK2-driven Parkinson’s disease Global Phase 2 clinical trial ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...